4//SEC Filing
Kelley Shannon T 4
Accession 0002034056-25-000009
CIK 0001157601other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:33 PM ET
Size
16.7 KB
Accession
0002034056-25-000009
Insider Transaction Report
Form 4
Kelley Shannon T
General Counsel
Transactions
- Sale
Common Stock
2025-08-18$375.75/sh−190$71,393→ 9,215 total - Sale
Common Stock
2025-08-18$374.13/sh−68$25,441→ 9,405 total - Sale
Common Stock
2025-08-18$376.62/sh−42$15,818→ 9,173 total - Sale
Common Stock
2025-08-18$369.64/sh−126$46,575→ 9,893 total - Sale
Common Stock
2025-08-18$372.44/sh−252$93,855→ 9,473 total - Sale
Common Stock
2025-08-18$370.06/sh−84$31,085→ 9,809 total - Sale
Common Stock
2025-08-18$358.66/sh−458$164,266→ 10,019 total - Sale
Common Stock
2025-08-18$371.35/sh−84$31,193→ 9,725 total
Footnotes (8)
- [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.02 to $369.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.22 to $371.48, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.25 to $372.76, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.77 to $374.36, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.46 to $376.06, inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.60 to $376.64, inclusive.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0002034056
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 5:33 PM ET
- Size
- 16.7 KB